{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:06:25Z","timestamp":1765422385033,"version":"3.30.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,17]]},"DOI":"10.7759\/cureus.75908","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:35:51Z","timestamp":1734500151000},"source":"Crossref","is-referenced-by-count":1,"title":["Heterogeneity of the Alpha-Smooth Muscle Actin Tumor Score in Breast Cancer Cells Significantly Affects Tumor Invasiveness, Recurrence, and Patient Survival"],"prefix":"10.7759","author":[{"given":"Mihaela-Maria","family":"Pasca Fenesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei Alexandru","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Melnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca Maria","family":"Cimpean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Veniamin","family":"Cozma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina Gabriela","family":"Negru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69006-1","article-title":"Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021","volume":"14","author":"Barclay NL","year":"2024","unstructured":"Barclay NL, Burn E, Delmestri A, et al.. Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021. Sci Rep. 2024, 14:19069. 10.1038\/s41598-024-69006-1","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-18-0836","article-title":"Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple-negative breast cancer","volume":"17","author":"Humphries BA","year":"2019","unstructured":"Humphries BA, Buschhaus JM, Chen YC, et al.. Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple-negative breast cancer. Mol Cancer Res. 2019, 17:1142-54. 10.1158\/1541-7786.MCR-18-0836","journal-title":"Mol Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112653","article-title":"The cytoskeletal protein cyclase-associated protein 1 (CAP1) in breast cancer: context-dependent roles in both the invasiveness and proliferation of cancer cells and underlying cell signals","volume":"20","author":"Hasan R","year":"2019","unstructured":"Hasan R, Zhou GL. The cytoskeletal protein cyclase-associated protein 1 (CAP1) in breast cancer: context-dependent roles in both the invasiveness and proliferation of cancer cells and underlying cell signals. Int J Mol Sci. 2019, 20:10.3390\/ijms20112653","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biophys-042910-155359","article-title":"Actin structure and function","volume":"40","author":"Dominguez R","year":"2011","unstructured":"Dominguez R, Holmes KC. Actin structure and function. Annu Rev Biophys. 2011, 40:169-86. 10.1146\/annurev-biophys-042910-155359","journal-title":"Annu Rev Biophys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1063\/5.0096188","article-title":"The actin cytoskeleton: morphological changes in pre- and fully developed lung cancer","volume":"3","author":"Basu A","year":"2022","unstructured":"Basu A, Paul MK, Weiss S. The actin cytoskeleton: morphological changes in pre- and fully developed lung cancer. Biophys Rev (Melville). 2022, 3:041304. 10.1063\/5.0096188","journal-title":"Biophys Rev (Melville)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102245","article-title":"Involvement of actin and actin-binding proteins in carcinogenesis","volume":"9","author":"Izdebska M","year":"2020","unstructured":"Izdebska M, Zieli\u0144ska W, Ha\u0142as-Wi\u015bniewska M, Grzanka A. Involvement of actin and actin-binding proteins in carcinogenesis. Cells. 2020, 9:10.3390\/cells9102245","journal-title":"Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101051","article-title":"The remodelling of actin composition as a hallmark of cancer","volume":"14","author":"Suresh R","year":"2021","unstructured":"Suresh R, Diaz RJ. The remodelling of actin composition as a hallmark of cancer. Transl Oncol. 2021, 14:101051. 10.1016\/j.tranon.2021.101051","journal-title":"Transl Oncol"},{"key":"ref8","article-title":"Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast","volume":"46","author":"C\u00eempean AM","year":"2005","unstructured":"C\u00eempean AM, Raica M, Nari\u0163a D. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast. Rom J Morphol Embryol. 2005, 46:123-9.","journal-title":"Rom J Morphol Embryol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201802144","article-title":"Myoepithelial cells are a dynamic barrier to epithelial dissemination","volume":"217","author":"Sirka OK","year":"2018","unstructured":"Sirka OK, Shamir ER, Ewald AJ. Myoepithelial cells are a dynamic barrier to epithelial dissemination. J Cell Biol. 2018, 217:3368-81. 10.1083\/jcb.201802144","journal-title":"J Cell Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153823","article-title":"Reassessing breast cancer-associated fibroblasts (CAFs) interactions with other stromal components and clinico-pathologic parameters by using immunohistochemistry and digital image analysis (DIA)","volume":"15","author":"Barb AC","year":"2023","unstructured":"Barb AC, Fenesan MP, Pirtea M, et al.. Reassessing breast cancer-associated fibroblasts (CAFs) interactions with other stromal components and clinico-pathologic parameters by using immunohistochemistry and digital image analysis (DIA). Cancers (Basel). 2023, 15:10.3390\/cancers15153823","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073686","article-title":"CD34+ stromal cells\/telocytes as a source of cancer-associated fibroblasts (CAFs) in invasive lobular carcinoma of the breast","volume":"22","author":"D\u00edaz-Flores L","year":"2021","unstructured":"D\u00edaz-Flores L, Guti\u00e9rrez R, Gonz\u00e1lez-G\u00f3mez M, Garc\u00eda MP, D\u00edaz-Flores L Jr, Carrasco JL, Mart\u00edn-Vasallo P. CD34+ stromal cells\/telocytes as a source of cancer-associated fibroblasts (CAFs) in invasive lobular carcinoma of the breast. Int J Mol Sci. 2021, 22:10.3390\/ijms22073686","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1281650","article-title":"Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic invasive lobular carcinoma","volume":"13","author":"Batra H","year":"2023","unstructured":"Batra H, Ding Q, Pandurengan R, et al.. Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic invasive lobular carcinoma. Front Oncol. 2023, 13:1281650. 10.3389\/fonc.2023.1281650","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06627-y","article-title":"Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses","volume":"194","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Luo X, Chen M, et al.. Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses. Breast Cancer Res Treat. 2022, 194:279-95. 10.1007\/s10549-022-06627-y","journal-title":"Breast Cancer Res Treat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16958","article-title":"The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis","volume":"12","author":"Cui M","year":"2024","unstructured":"Cui M, Dong H, Duan W, Wang X, Liu Y, Shi L, Zhang B. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis. PeerJ. 2024, 12:e16958. 10.7717\/peerj.16958","journal-title":"PeerJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1633","article-title":"Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer","volume":"75","author":"Ao Z","year":"2015","unstructured":"Ao Z, Shah SH, Machlin LM, et al.. Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer. Cancer Res. 2015, 75:4681-7. 10.1158\/0008-5472.CAN-15-1633","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6910","article-title":"TP53 upregulates \u03b1\u2011smooth muscle actin expression in tamoxifen\u2011resistant breast cancer cells","volume":"41","author":"Kim S","year":"2019","unstructured":"Kim S, You D, Jeong Y, Yu J, Kim SW, Nam SJ, Lee JE. TP53 upregulates \u03b1\u2011smooth muscle actin expression in tamoxifen\u2011resistant breast cancer cells. Oncol Rep. 2019, 41:1075-82. 10.3892\/or.2018.6910","journal-title":"Oncol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10843","article-title":"Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction","volume":"8","author":"Jeon M","year":"2017","unstructured":"Jeon M, You D, Bae SY, et al.. Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction. Oncotarget. 2017, 8:50570-81. 10.18632\/oncotarget.10843","journal-title":"Oncotarget"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00414-6","article-title":"Deep learning and transfer learning identify breast cancer survival subtypes from single-cell imaging data","volume":"3","author":"Yadav S","year":"2023","unstructured":"Yadav S, Zhou S, He B, Du Y, Garmire LX. Deep learning and transfer learning identify breast cancer survival subtypes from single-cell imaging data. Commun Med (Lond). 2023, 3:187. 10.1038\/s43856-023-00414-6","journal-title":"Commun Med (Lond)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-022-00152-1","article-title":"Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line","volume":"34","author":"Ambrose JM","year":"2022","unstructured":"Ambrose JM, Veeraraghavan VP, Vennila R, et al.. Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line. J Egypt Natl Canc Inst. 2022, 34:51. 10.1186\/s43046-022-00152-1","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-022-00432-7","article-title":"lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p","volume":"23","author":"Peng Y","year":"2022","unstructured":"Peng Y, Huang X, Wang H. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p. BMC Mol Cell Biol. 2022, 23:34. 10.1186\/s12860-022-00432-7","journal-title":"BMC Mol Cell Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2416","article-title":"Epithelial to mesenchymal transition and breast cancer","volume":"11","author":"Tomaskovic-Crook E","year":"2009","unstructured":"Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009, 11:213. 10.1186\/bcr2416","journal-title":"Breast Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2017","article-title":"Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype","volume":"68","author":"Sarri\u00f3 D","year":"2008","unstructured":"Sarri\u00f3 D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68:989-97. 10.1158\/0008-5472.CAN-07-2017","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2587-4","article-title":"Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients","volume":"16","author":"Aktas B","year":"2016","unstructured":"Aktas B, Kasimir-Bauer S, M\u00fcller V, et al.. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients. BMC Cancer. 2016, 16:522. 10.1186\/s12885-016-2587-4","journal-title":"BMC Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu X","year":"2024","unstructured":"Gu X, Wei S, Lv X. Circulating tumor cells: from new biological insights to clinical practice. Signal Transduct Target Ther. 2024, 9:226. 10.1038\/s41392-024-01938-6","journal-title":"Signal Transduct Target Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.360","article-title":"c-Src differentially regulates the functions of microtentacles and invadopodia","volume":"29","author":"Balzer EM","year":"2010","unstructured":"Balzer EM, Whipple RA, Thompson K, et al.. c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 2010, 29:6402-8. 10.1038\/onc.2010.360","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118691","article-title":"Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD","volume":"1867","author":"McNeill MC","year":"2020","unstructured":"McNeill MC, Wray J, Sala-Newby GB, et al.. Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD. Biochim Biophys Acta Mol Cell Res. 2020, 1867:118691. 10.1016\/j.bbamcr.2020.118691","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.299","article-title":"Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage","volume":"28","author":"Provenzano PP","year":"2009","unstructured":"Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene. 2009, 28:4326-43. 10.1038\/onc.2009.299","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403062121","article-title":"Genetic variation drives cancer cell adaptation to ECM stiffness","volume":"121","author":"Wang TC","year":"2024","unstructured":"Wang TC, Sawhney S, Morgan D, et al.. Genetic variation drives cancer cell adaptation to ECM stiffness. Proc Natl Acad Sci U S A. 2024, 121:e2403062121. 10.1073\/pnas.2403062121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2021.11.007","article-title":"Cancer cell mechanobiology: a new frontier for cancer research","volume":"2","author":"Yu W","year":"2022","unstructured":"Yu W, Sharma S, Rao E, Rowat AC, Gimzewski JK, Han D, Rao J. Cancer cell mechanobiology: a new frontier for cancer research. J Natl Cancer Cent. 2022, 2:10-7. 10.1016\/j.jncc.2021.11.007","journal-title":"J Natl Cancer Cent"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6633\/ab1628","article-title":"The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells","volume":"82","author":"Mierke CT","year":"2019","unstructured":"Mierke CT. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells. Rep Prog Phys. 2019, 82:064602. 10.1088\/1361-6633\/ab1628","journal-title":"Rep Prog Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325322-heterogeneity-of-the-alpha-smooth-muscle-actin-tumor-score-in-breast-cancer-cells-significantly-affects-tumor-invasiveness-recurrence-and-patient-survival","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:35:56Z","timestamp":1734500156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325322-heterogeneity-of-the-alpha-smooth-muscle-actin-tumor-score-in-breast-cancer-cells-significantly-affects-tumor-invasiveness-recurrence-and-patient-survival"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.75908","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}